Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...

VRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...

Vertex Pharmaceuticals (VRTX) on Tuesday announced that the European Commission has granted approval for Alyftrek for the ...

Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.

Vertex Pharmaceuticals today announced that the European Commission has granted approval for Alyftrek ...

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...

Consanguineous marriages are a deeply rooted tradition in Pakistan, but they come with a heavy cost: a rising prevalence of genetic disorders like thalassemia, cystic fibrosis, and metabolic condition ...

There are at least six kinds of diabetes you should know about. Endocrinologists explain the causes, symptoms, and treatments ...

Sickle cell is now the fastest growing genetic condition in the United Kingdom and can cause organ damage and strokes.